Tag Archives: Acute

Givlaari Approved for Acute Hepatic Porphyria

News Consumer News Givlaari Approved for Acute Hepatic Porphyria FRIDAY, Nov. 22, 2019 — On Wednesday, the U.S. Food and Drug Administration announced the approval of Givlaari (givosiran) for the treatment of acute hepatic porphyria. Previous treatment options for this genetic disorder have only provided partial relief from the pain of porphyria attacks, according to… Read More »

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Severe Rhabdomyolysis in a Patient With Acute Influenza Infection

January 03, 2019 This article originally appeared here. Share this content: Rhabdomyolysis is characterized by breakdown of muscle tissue A recently published case report describes the case of a 29-year-old male patient with influenza-induced rhabdomyolysis and highlights the need to assess creatinine kinase (CK) levels of patients hospitalized with influenza. The patient, who had a… Read More »

FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia

FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia Print this page November 21, 2018 — The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75… Read More »